Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center

Supportive Care in Cancer

Volumn 17, Issue 10, 2009, Pages 1311-1315

  Lal, Lincy S ^a   Gerber, Donna L ^a   Lau, Jason ^a   Dana, William ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hypersensitivity reactions; Premedications; Weekly paclitaxel

Indexed keywords

CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; HYDROCORTISONE; PACLITAXEL;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; BACKACHE; CANCER CENTER; CANCER CHEMOTHERAPY; CHEST TIGHTNESS; CHILL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DEMOGRAPHY; DIAPHORESIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPNEA; ELECTRONIC MEDICAL RECORD; FLUSHING; HEADACHE; HEARTBURN; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTENSION; LEG PAIN; NAUSEA; PREMEDICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIDE EFFECT; TERTIARY HEALTH CARE; THORAX PAIN; URTICARIA; VOMITING; WHEEZING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PACLITAXEL; PREMEDICATION; RETROSPECTIVE STUDIES;

EID: 70349317357     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0588-4     Document Type: Article

References (16)

1. W Akerly WM Sikov F Cummings 1997 Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer. A preliminary report Semin Oncol 24 87 90
2. AY Chang L Boros R Asbury 1997 Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancers Semin Oncol 24 69 71
3. AR Dyer J Stamler DM Berkson 1975 High blood-pressure: a risk factor for cancer mortality? Lancet 1 1051 1056
4. PKY Goon FH Messerli GYH Lip 2006 Hypertension and breast cancer: an association revisited? J Hum Hypertens 20 722 724
5. Y Itoh T Sendo T Hirakawa 2004 Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity Am J Respir Crit Care Med 169 113 119
6. DHM Lau J Ryu D Gandara 1999 Concurrent twice weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer Semin Radiat Oncol 9 117 120
7. HJ Lenz 2007 Management and preparedness for infusion and hypersensitivity reactions Oncologist 12 601 609
8. A Milani T DePas C Noberasco 2007 A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care Lung Cancer 58 300 301
9. National Cancer Institute (2006) Common terminology criteria for adverse events v3.0 (CTCAE). National Cancer Institute, Bethesda
10. J Quock G Dea M Tanaka 2002 Premedication strategy for weekly paclitaxel Cancer Invest 20 666 672
11. EK Rowinsky N Onetto RM Canetta 1992 Taxol: the first of the taxanes, an important new class of antitumor agents Semin Oncol 19 646 662
12. A Ruiz-Casado J Calzas J Garcia 2006 Life-threatening adverse drug reaction to paclitaxel. Postmarketing surveillance Clin Transl Oncol 8 60 61
13. JA Sparano M Wang D Martino 2008 Weekly paclitaxel in the adjuvant treatment of breast cancer N Engl J Med 358 1663 671
14. University of Texas M. D. Anderson (2008) Paclitaxel. Lexi-Comp ONLINE, Hudson
15. RB Weiss RC Donehower PH Wiernik 1990 Hypersensitivity reaction from taxol J Clin Oncol 7 1263 1268
16. J Zidan O Hussein A Abzah 2008 Oral premedication for the prevention of hypersensitivity reactions to paclitaxel Med Oncol 25 274 278